Glycosylated hemoglobin (HbA1c) is an index of estimated average blood glucose over the preceding three months, giving an estimate of long-term glycemic status. Its value is used both for the diagnosis and monitoring the blood glucose control of the patients with diabetes mellitus. Though a widely used tool the value of HbA1c is influenced by various factors which, if not kept in mind of the treating clinician may lead to a false diagnosis or false sense of diabetic control. The authors give a brief overview of the HbA1c and the factors affecting its value.
Keywords: Diabetes mellitus; Estimated average glucose; Glycosylated hemoglobin; Glycemic control
×
How to Cite This Article
Vancouver
Rawal G, Yadav S, Kumar R, Singh A. Glycosylated hemoglobin (HbA1C): A brief overview for clinicians [Internet]. IP Indian J Immunol Respir Med. 2025 [cited 2025 Sep 09];1(2):33-36. Available from: https://doi.org/
APA
Rawal, G., Yadav, S., Kumar, R., Singh, A. (2025). Glycosylated hemoglobin (HbA1C): A brief overview for clinicians. IP Indian J Immunol Respir Med, 1(2), 33-36. https://doi.org/
MLA
Rawal, Gautam, Yadav, Sankalp, Kumar, Raj, Singh, Amrita. "Glycosylated hemoglobin (HbA1C): A brief overview for clinicians." IP Indian J Immunol Respir Med, vol. 1, no. 2, 2025, pp. 33-36. https://doi.org/
Chicago
Rawal, G., Yadav, S., Kumar, R., Singh, A.. "Glycosylated hemoglobin (HbA1C): A brief overview for clinicians." IP Indian J Immunol Respir Med 1, no. 2 (2025): 33-36. https://doi.org/